Эффективность тенипозида в химиолучевом лечении злокачественных глиом головного мозга

А. Ю. Штефан, Dina Sakaeva, Ф. Ф. Муфазалов · Медицинский вестник Башкортостана · 2007

Results stay unsatisfactory in spite of modern strategy of patients treatment with malignant supratentorial glioma based on high technology of surgical, radial and also medicinal treatment. Application of tenyposides cytostatic agent in circuitry of postoperative radiotherapy was suggested by the authors for the purpose of effectiveness increase of patients combined therapy with malignant glioma. Findings of investigation showed that use of tenyposide as radiomodifier is effective, safe, well withstood, it doesnt demand any additional spending except the cost of medicine itself and its highly perspective for further inquiry. Usability of cytostatic agent and low profile of its toxicity allow to carry out out-patient treatment.

Cited by 0 works.

Authors